Amedisys (AMED)
(Delayed Data from NSDQ)
$96.87 USD
-0.43 (-0.44%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $96.88 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
Balance Sheet
Fiscal Year End for Amedisys, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 139 | 54 | 46 | 83 | 96 |
Receivables | 313 | 297 | 275 | 255 | 238 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 45 | 38 | 36 | 23 | 16 |
Total Current Assets | 497 | 389 | 357 | 362 | 351 |
Net Property & Equipment | 42 | 16 | 18 | 24 | 28 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 48 | 21 |
Intangibles | 1,347 | 1,389 | 1,307 | 1,007 | 723 |
Deposits & Other Assets | 85 | 80 | 73 | 33 | 55 |
Total Assets | 2,060 | 1,976 | 1,857 | 1,567 | 1,263 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 28 | 44 | 38 | 43 | 31 |
Current Portion Long-Term Debt | 36 | 16 | 13 | 11 | 10 |
Current Portion Capital Leases | 26 | 0 | 0 | 0 | 0 |
Accrued Expenses | 277 | 263 | 292 | 313 | 258 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 106 | 0 | 0 | 60 | 0 |
Total Current Liabilities | 474 | 356 | 374 | 456 | 327 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 41 | 20 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 362 | 419 | 432 | 205 | 232 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 5 | 5 | 34 | 6 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 940 | 870 | 881 | 756 | 621 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 787 | 755 | 728 | 698 | 645 |
Retained Earnings | 748 | 758 | 639 | 430 | 246 |
Other Equity | 53 | 55 | 45 | 2 | 1 |
Treasury Stock | 469 | 461 | 436 | 319 | 251 |
Total Shareholder's Equity | 1,120 | 1,107 | 976 | 811 | 642 |
Total Liabilities & Shareholder's Equity | 2,060 | 1,976 | 1,857 | 1,567 | 1,263 |
Total Common Equity | 1,120 | 1,107 | 976 | 811 | 642 |
Shares Outstanding | 32.60 | 32.40 | 32.60 | 32.80 | 32.20 |
Book Value Per Share | 34.35 | 34.15 | 29.95 | 24.72 | 19.92 |
Fiscal Year End for Amedisys, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 157 | 121 | 139 | 94 | 111 |
Receivables | 357 | 359 | 313 | 320 | 279 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 42 | 46 | 45 | 54 | 37 |
Total Current Assets | 556 | 526 | 497 | 467 | 427 |
Net Property & Equipment | 45 | 43 | 42 | 40 | 36 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,346 | 1,346 | 1,347 | 1,348 | 1,349 |
Deposits & Other Assets | 87 | 86 | 85 | 84 | 85 |
Total Assets | 2,117 | 2,090 | 2,060 | 2,027 | 1,982 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 27 | 36 | 28 | 35 | 39 |
Current Portion Long-Term Debt | 38 | 37 | 36 | 35 | 31 |
Current Portion Capital Leases | 0 | 0 | 26 | 0 | 0 |
Accrued Expenses | 283 | 279 | 277 | 266 | 261 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 106 | 106 | 106 | 106 | 106 |
Total Current Liabilities | 480 | 485 | 474 | 468 | 462 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 47 | 43 | 41 | 35 | 28 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 351 | 356 | 362 | 367 | 370 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 1 | 2 | 2 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 938 | 947 | 940 | 934 | 922 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 803 | 795 | 787 | 777 | 769 |
Retained Earnings | 795 | 762 | 748 | 729 | 703 |
Other Equity | 54 | 54 | 53 | 54 | 54 |
Treasury Stock | 473 | 469 | 469 | 466 | 465 |
Total Shareholder's Equity | 1,179 | 1,143 | 1,120 | 1,094 | 1,061 |
Total Liabilities & Shareholder's Equity | 2,117 | 2,090 | 2,060 | 2,027 | 1,982 |
Total Common Equity | 1,179 | 1,143 | 1,120 | 1,094 | 1,061 |
Shares Outstanding | 32.70 | 32.60 | 32.60 | 32.60 | 32.60 |
Book Value Per Share | 36.05 | 35.05 | 34.35 | 33.54 | 32.54 |